Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

November 29 2023 - FDA names chief scientist Bumpus as Woodcock’s successor

FDA names chief scientist Bumpus as Woodcock’s successor
FDA launches probe of malignancies linked to CAR-T therapies
FDA kicks off review of Karuna’s schizophrenia drug KarXT
Lilly puts potential $660M on the line for protein-protein interaction blockers
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Boehringer Ingelheim to collaborate with Phenomic AI on stroma-rich cancers

Medical Marketing and Media

Wednesday, November 29, 2023 - 11:38pm

tags:

Boehringer Ingelheim, artificial intelligence, Phenomic AI, stroma-rich cancers

BioMarin secures hemophilia gene therapy coverage in Germany

BioPharma Dive

Wednesday, November 29, 2023 - 11:35pm

tags:

Biomarin, Roctavian, gene therapy, Germany, hemophilia

Novocure Is the Latest Medtech Company to Cut Jobs

Medical Devices and Diagnostics Industry

Wednesday, November 29, 2023 - 11:33pm

tags:

Medtech, Novocure, layoffs

Cigna, Humana in talks to merge

BioPharma Dive

Wednesday, November 29, 2023 - 11:30pm

tags:

insurers, M&A, Cigna, Humana

FDA names chief scientist Bumpus as Woodcock’s successor

BioPharma Dive

Wednesday, November 29, 2023 - 12:08pm

tags:

FDA, regulatory, Janet Woodcock, Namandjé Bumpus

Amgen expands pact with Amazon to usher drug manufacturing into the AI era

Fierce Pharma

Wednesday, November 29, 2023 - 12:06pm

tags:

Amgen, artificial intelligence, Amazon, drug manufacturing

FDA Launches Probe of Malignancies Linked to CAR-T Therapies

BioSpace

Wednesday, November 29, 2023 - 12:04pm

tags:

CAR-T, side effects, FDA

FDA Rejects Aldeyra’s Dry Eye Drug, Cites Need for Additional Trial

BioSpace

Wednesday, November 29, 2023 - 12:03pm

tags:

Aldeyra Therapeutics, reproxalap, FDA, dry eye disease

On blockbuster path, Argenx's red-hot Vyvgart comes up short in thrombocytopenia trial

Fierce Pharma

Wednesday, November 29, 2023 - 12:02pm

tags:

Argenx, Vyvgart, thrombocytopenia, clinical trials

AbbVie cues up filing for c-Met ADC in lung cancer

Pharmaphorum

Wednesday, November 29, 2023 - 12:00pm

tags:

AbbVie, Teliso-V, clinical trials, lung cancer

FDA kicks off review of Karuna’s schizophrenia drug KarXT

Pharmaphorum

Wednesday, November 29, 2023 - 11:57am

tags:

Karuna, KarXT, FDA, schizophrenia

Gilead cuts 7% of staff at Kite Pharma unit as 'refreshed business strategy' introduced

Fierce Pharma

Wednesday, November 29, 2023 - 11:55am

tags:

Kite Pharma, Gilead Sciences, layoffs

J&J Sheds Light on Plans for Surgical Robot

Medical Devices and Diagnostics Industry

Wednesday, November 29, 2023 - 11:53am

tags:

JNJ, Medtronic, Intuitive Surgical, robotic surgery, Medtech

Jazz halts sleep disorder med trial over 'visual disturbances' and CV effects

Fierce Biotech

Wednesday, November 29, 2023 - 11:50am

tags:

Jazz Pharma, phase 1 sleep disorder, Sumitomo Pharma, JZP441

Lilly Puts Potential $660M on the Line for Protein-Protein Interaction Blockers

BioSpace

Wednesday, November 29, 2023 - 11:49am

tags:

Eli Lilly, PRISM BioLab, small molecule inhibitors

Medtronic Makes a Double Play for Atrial Fibrillation

Medical Devices and Diagnostics Industry

Wednesday, November 29, 2023 - 11:47am

tags:

Medtronic, PulseSelect, pulsed field ablation, atrial fibrillation, Medtech, CE Mark

Teva drops patent case against Lilly after two Ajovy patents deemed invalid

Fierce Pharma

Tuesday, November 28, 2023 - 11:40pm

tags:

Teva Pharmaceutical, legal, Eli Lilly, Ajovy, patents, migraines

Novartis sees brighter sales future as R&D revamp continues

BioPharma Dive

Tuesday, November 28, 2023 - 11:36pm

tags:

Pfizer takes Poland to court over alleged missed COVID-19 vaccine payments

Fierce Pharma

Tuesday, November 28, 2023 - 11:34pm

tags:

Pfizer, vaccines, COVID-19, Poland

WHO authorizes emergency use of Novavax's updated COVID shot

Reuters

Tuesday, November 28, 2023 - 11:32pm

tags:

Novavax, WHO, COVID-19, vaccines

Pages

Latest CP Wire Articles

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

Latest Pharmagather Articles

Drug Channels News Roundup, November 2023: My $0.02 on Express Scripts’ Cost-Based Pricing, Mark Cuban vs. PBMs, Dual-WAC Strategies, Pharmacy Shakeout, and Adam vs. Rocky

Drug Channels

Simplify and Accelerate Benefits Verification with a Fully Integrated, Adaptable Platform

Drug Channels

Medicare Part D in 2024: Mapping Large Chains' Position in 2024’s Preferred Pharmacy Networks

Drug Channels

Drug Channels Outlook 2024 (NEW Live Video Webinar)

Drug Channels

Four Trends That Are Shaping the Future of Market Access

Drug Channels

FDA’s OPDP Issues Two New Untitled Letters

eye on fda

Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies

Drug Channels

Is Your Hub Partner Missing the Therapeutic Area Expertise You Need?

Drug Channels

Drug Channels News Roundup, October 2023: CVS & Humira Biosimilars, GLP-1 G2N Bubble, 340B Abuses, Rite Aid's Endgame, Mark Cuban Update, and an Epic Meetup

Drug Channels